About: Coronavirus Disease 2019 (COVID-19) in Cancer Patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Coronavirus Disease 2019 (COVID-19) in Cancer Patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Coronavirus Disease 2019 (COVID-19) in Cancer Patients
Creator	Malik, Bilal Cancarevic, Ivan Tathineni, Praveena
Source	Medline; PMC; WHO
abstract	The Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the most talked-about clinical entity in early 2020. As an infection that spreads easily and has a significant mortality rate, it has caused global panic rarely seen before. Many of the measures taken by governments worldwide will have long-lasting impacts on the wellbeing of the population at large. It has been widely reported that the most vulnerable patients have been most negatively affected by SARS-CoV-2 (COVID-19). In this study, we have tried to search the currently available data on the outcomes of infected cancer patients. Most of the data points to the very challenging nature of treating such patients. Their overall outcomes seem to be worse than in the general population, and it may be difficult to differentiate which potential complications are a result of the primary oncologic disease versus the infection. Management presents its own set of challenges, including but not limited to, deciding whether postponing cancer treatment until the infection resolves is going to benefit the patient and how to organize all aspects of patient care when social contact is as limited as it is for patients newly diagnosed with COVID-19. We believe that as more data becomes available, it is going to be necessary to publish detailed guidelines on how to approach this unique clinical challenge.
has issue date	2020-04-26(xsd:dateTime)
bibo:doi	10.7759/cureus.7835
bibo:pmid	32467810
has license	cc-by
sha1sum (hex)	9a58c60dc120764ec3ebbccd363a53d90755255b
schema:url	https://doi.org/10.7759/cureus.7835
resource representing a document's title	Coronavirus Disease 2019 (COVID-19) in Cancer Patients
has PubMed Central identifier	PMC7250517
has PubMed identifier	32467810
schema:publication	Cureus
resource representing a document's body	covid:9a58c60dc120764ec3ebbccd363a53d90755255b#body_text
is schema:about of	named entity 'resolves' named entity 'caused' named entity 'disease' named entity 'entity' named entity 'EARLY' named entity 'DATA POINTS' named entity 'detailed' named entity 'COVID-19' named entity 'Management' named entity 'deciding' named entity 'measures' named entity 'severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)' named entity 'COVID-19' named entity 'limited' named entity 'Most' named entity 'Coronavirus' named entity 'SARS-CoV-2' named entity 'infection' named entity 'patient care' named entity 'widely reported' named entity 'Coronavirus Disease 2019' named entity 'COVID' named entity 'set' named entity 'COVID' named entity 'chemotherapy' named entity 'psychiatric disease' named entity 'acute infection' named entity 'COVID-19 infections' named entity 'adrenal carcinoma' named entity 'COVID' named entity 'co-morbidity' named entity 'COVID' named entity 'co-morbidities' named entity 'co-morbidity' named entity 'risk factor' named entity 'lung' named entity 'general population' named entity 'coronavirus' named entity 'SARS-CoV-2' named entity 'immunosuppression' named entity 'quality of life' named entity 'mental health' named entity 'co-morbidities' named entity 'co-morbidities' named entity 'intensive care unit' named entity 'risk factors' named entity 'anxiety' named entity 'ICU' named entity 'severe acute respiratory syndrome coronavirus' named entity 'weaker immune systems' named entity 'malignant' named entity 'renal cell carcinoma' named entity 'COVID' named entity 'ICU' named entity 'infection prevention' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'lung' named entity 'SARS-CoV-2 outbreak' named entity 'fever' named entity 'colorectal cancer' named entity 'D-dimer' named entity 'leukopenia' named entity 'chemotherapy' named entity 'psychological impact' named entity 'upper respiratory tract infection' named entity 'public health emergency' named entity 'COVID' named entity 'C-reactive protein' named entity 'myalgia' named entity 'bladder' named entity 'MERS-CoV' named entity 'diabetes mellitus' named entity 'chemotherapy' named entity 'infection' named entity 'United States' named entity 'COVID' named entity 'healthcare workers' named entity 'co-morbidities' named entity 'eosinopenia'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software